SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community anticipates the upcoming 4/20 cultural moment and potential cannabis rescheduling, generating strong discussions around its 'culture first' mission. Enthusiasts rally around its goal to advance global cannabis legalization and integrate real-world utility, proclaiming it 'like Bitcoin but way higher' in vibes and purpose.

Aster is a next-generation decentralized perpetual exchange that combines non-custodial trading with advanced features like hidden orders and multi-chain support. The platform emerged from the merger of Astherus and APX Finance in late 2024, with APX token holders able to migrate their holdings to ASTER.  Aster addresses the gap between centralized and decentralized exchanges by enabling traders to maintain full control of their assets while accessing deep liquidity and CEX-grade trading tools. The platform supports trading of both cryptocurrency perpetuals and U.S. stocks with up to 100x leverage, all settled on-chain in crypto without requiring traditional financial infrastructure.  The platform offers two distinct trading modes to accommodate different user needs. Simple Mode provides one-click, MEV-resistant trading with up to 1001x leverage for beginners, while Pro Mode delivers a full order book with advanced features like automated grid trading and hidden orders that remain invisible until execution.   Aster operates across BNB Chain, Ethereum, Solana, and Arbitrum without requiring bridging, with liquidity pooled across markets to support large trades with minimal slippage. A distinctive feature allows users to deposit yield-generating assets like asBNB or USDF as collateral, earning passive returns while trading, maximizing capital efficiency compared to platforms where collateral sits idle.  Aster received backing from YZi Labs (formerly Binance Labs), which holds a minority stake through a private fund managing over $10 billion on behalf of early Binance executives. Changpeng Zhao, founder of Binance, serves in an advisory role and has personally invested over $2.5 million worth of ASTER tokens.   The ASTER token serves multiple functions including governance rights, staking rewards through liquidity provision, and earning incentives through the platform's points program for traders and liquidity providers.

ASTERION

ASTER is intensely trending following reports of a personal endorsement and purchase by CZ, sparking widespread community debate about its potential to rival other perpetual decentralized exchanges like Hyperliquid, while bullish sentiment is also driven by recent listings and its significant token buyback program.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BNKR CRYPTO is trending due to its AI agent technology and deep integration within the Coinbase Base ecosystem, with recent exchange listings and the launch of the BankrWallet browser extension amplifying community excitement. Enthusiasts are actively buying dips, anticipating a significant price repricing and highlighting its consistent daily fee revenue, even as some question its volatility.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is generating significant discussion following a recent insider share sale by its CEO that has fueled negative sentiment and contributed to stock volatility, while the community actively weighs rumors of a potential buyout and anticipates key pipeline updates, including for its Casgevy gene therapy, ahead of upcoming healthcare conferences.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is generating significant buzz due to new integrations and rapid user growth, positioning it as a potential Layer 1 powerhouse that is notably holding strong amidst broader crypto market turbulence, even as the community debates its tokenomics and long-term valuation.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing extreme volatility after rapidly halting its new compounded GLP-1 weight-loss pill following FDA enforcement signals and a Department of Justice referral. The community is fiercely debating whether this regulatory setback spells disaster for the company or merely removes an overhang, creating a buying opportunity for its broader telehealth business amidst intense competition from big pharma.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 is trending as some traders utilize it for bearish market hedges against an overbought Dow, amidst broader concerns of economic uncertainty. Concurrently, the ticker $DOG is also heavily discussed in the crypto community for a Bitcoin-native memecoin, lauded for its fair launch and community-driven ethos.

Constellation Software Inc

Constellation Software is experiencing significant volatility, fueled by broader market fears surrounding AI's potential impact on the software sector and its recent drawdown. Despite these concerns, many investors are viewing the current valuation as a compelling buying opportunity, emphasizing the company's robust cash flow, disciplined acquisition strategy, and strong long-term fundamentals.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending amid a wave of analyst upgrades emphasizing its robust growth and position as a key AI infrastructure beneficiary, even as the software sector faces broader concerns about competition and AI disruption. The community is actively discussing whether the recent pullback presents a compelling buying opportunity for this cloud observability leader.

Under Armour, Inc. engages in the development, marketing, and distribution of branded performance apparel, footwear, and accessories for men, women, and youth. It operates through the following geographical segments: North America, EMEA, Asia-Pacific, Latin America, and Other. The company was founded by Kevin A. Plank in 1996 and is headquartered in Baltimore, MD.

Under Armour Inc - Ordinary Shares - Class A

Under Armour Inc Class A

Under Armour is experiencing increased attention following an unexpectedly strong Q3 earnings report and a raised outlook, which, combined with Fairfax Financial's significant stake accumulation, has fueled community discussion about a potential short squeeze and a brand turnaround.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CNO Beats Q4 Earnings Estimates on Higher Collected Premiums

CNO Financial posts a Q4 earnings beat as higher collected premiums across annuity, life and health products lift results despite rising costs.

MetLife Q4 Earnings Beat Estimates on Increasing Volumes

MET's Q4 adjusted EPS beat estimates as higher volumes lifted Asia, Group Benefits, RIS and EMEA, offset partly by a Mexico VAT hit.

American Financial Group (AFG) Surpasses Q4 Earnings Estimates

American Financial (AFG) delivered earnings and revenue surprises of +14.66% and -1.37%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

WCM Investment Management LLC Sells 53,204 Shares of Skyward Specialty Insurance Group, Inc. $SKWD

WCM Investment Management LLC reduced its stake in shares of Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD - Free Report) by 12.1% in the third quarter, according to the company in its most...

Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD) Given Consensus Recommendation of "Buy" by Analysts

Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD - Get Free Report) has been assigned a consensus recommendation of "Buy" from the thirteen research firms that are currently covering the company...

AXP Q4 Earnings Lag Estimates on Rising Customer Engagement Costs

American Express posts Q4 EPS growth and a revenue beat, but higher customer engagement and operating costs drag results despite strong Card Member spending.

MetLife Gears Up to Report Q4 Earnings: Key Estimates to Note

MET prepares to report Q4 results, with earnings and revenues expected to rise, driven by premium growth and stronger international operations.

Synchrony Q4 Earnings Beat Estimates on Improved Efficiency

SYF's Q4 EPS of $2.18 beat estimates as efficiency improves, purchase volume rises and credit loss provisions fall despite softer loan receivables.

Can HIG Offset Rising Expenses in Q4 With Higher Premiums?

Hartford Insurance heads into Q4 with higher premiums lifting revenue expectations, but rising operating costs and digital investments may weigh on margins.

Will Skyward (SKWD) Beat Estimates Again in Its Next Earnings Report?

Skyward (SKWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Skyward Specialty Insurance Group, Inc. is a holding company, which engages in the provision of commercial property and casualty products and solutions on a non-admitted and admitted basis. It specializes in the healthcare professional liability, industry solutions, management and professional liability, medical stop-loss, programs and captive solutions, specialty property and liability, and surety. It operates through the following divisions: Accident & Health, Captives, Global Property & Agriculture, Industry Solutions, Professional Lines, Programs, Surety and Transactional E&S. Skyward Specialty Insurance Group was founded by Stephen Lyndon Way on January 3, 2006 and is headquartered in Houston, TX.

Skyward Specialty Insurance Group Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$1.03	--	--	N/A
Q3 '25	$0.89	$1.05	18.38%	BEAT
Q2 '25	$0.86	$0.89	3.14%	BEAT
Q1 '25	$0.77	$0.90	16.24%	BEAT
Q4 '24	$0.77	$0.80	3.26%	BEAT

SKWD
Skyward Specialty Insurance Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SKWD News

SKWDSkyward Specialty Insurance Group Inc